Financhill
Back

EyePoint Pharmaceuticals Vs. Kyndryl Holdings Industry Stock Comparison

Buy
55

EYPT
EyePoint Pharmaceuticals

Last Price:
8.94
Seasonality Move:
28.93%
Sell
22

KD
Kyndryl Holdings

Last Price:
33.07
Seasonality Move:
21.65%
Buy
55
EyePoint Pharmaceuticals (EYPT) is a Buy

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $8.35. The Score for EYPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • EYPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
22
Kyndryl Holdings (KD) is a Sell

Is Kyndryl Holdings a Buy, Sell or Hold?

  • The current Kyndryl Holdings [KD] share price is $32.49. The Score for KD is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • KD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $8.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing selling pressure, which indicates risk of future bearish movement.

KD Stock Price Chart

What is Kyndryl Holdings's stock price today?

  • The Kyndryl Holdings share price today is $32.49
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KD is experiencing buying pressure, which is a positive indicator for future bullish movement.

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.32 Sell
Relative Strength Index (14 RSI): 35.82 Sell
Chaikin Money Flow: -1872551 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.53 - 11.89) Sell
Bollinger Bands (100): (8.13 - 10.51) Sell

KD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.52 Buy
Relative Strength Index (14 RSI): 83.94 Buy
Chaikin Money Flow: 4050180 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.38 - 28.4) Buy
Bollinger Bands (100): (22.65 - 26.71) Buy

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.58 Sell
20-day SMA: 10.78 Sell
50-day SMA: 9.77 Sell
200-day SMA: 13.55 Sell
8-day EMA: 9.47 Sell
20-day EMA: 10.14 Sell
50-day EMA: 9.98 Sell
200-day EMA: 11.48 Sell

KD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.77 Buy
20-day SMA: 26.27 Buy
50-day SMA: 24.78 Buy
200-day SMA: 23.96 Buy
8-day EMA: 28.86 Buy
20-day EMA: 27.1 Buy
50-day EMA: 25.54 Buy
200-day EMA: 23.47 Buy

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.31 per share.

Kyndryl Holdings Earnings Growth & KD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.37 per share, and an increase next year of $1.26 per share.

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kyndryl Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):